Navigation Links
Dendreon Announces Presentation of PROVENGE Data at the American Society of Hematology and the Society of Urologic Oncology Annual Meetings
Date:12/3/2010

SEATTLE, Dec. 3, 2010 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the following PROVENGE® (sipuleucel-T) data presentations taking place at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida and the Society of Urologic Oncology (SUO) Annual Meeting in Bethesda, Maryland.

The following data presentations will take place at the ASH Annual Meeting on Saturday, December 4, 2010, at 5:30 p.m. ET:

  • A poster titled, "Elevated Eosinophils Following Treatment with Sipuleucel-T in Men with Prostate Cancer is Associated with Antigen-Specific Immune Response and Prolonged Survival (abstract #1491)," presented by Robert Sims, M.D., senior medical director of clinical affairs of Dendreon.
  • A poster titled, "Increased Gamma Globulin Following Immunotherapy with Sipuleucel-T is Associated with Antigen-Specific Antibody Responses (abstract #1738)," presented by Dr. Sims.

The following data presentation will take place at the SUO Annual Meeting on Thursday, December 9, 2010, at 4:00 p.m. ET:

  • A poster titled, "Sipuleucel-T Immunotherapy for Advanced Prostate Cancer; Integrated Results from Randomized, Double-Blind, Controlled Trials (abstract #22)," presented by Allan Pantuck, M.D., associate professor of urology at the University of California, Los Angeles.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendre
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Webcast Presentation at Credit Suisse 2010 Health Care Conference
2. Dendreon Reports Third Quarter 2010 Financial Results
3. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
4. Dendreon Statement on CMS National Coverage Analysis
5. Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
6. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
7. Dendreon Reports Fourth Quarter and 2009 Year End Financial Results
8. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
9. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
10. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
11. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 The ambulance equipment ... decade due to the recession, an unstable ... advancements. This BCC Research report analyzes present ... the ambulance and emergency medical services equipment ... hemorrhage control devices, equipment used for burn ...
(Date:9/17/2014)... , Sept. 17, 2014  Dr. Stephen ... the White House today for National Recovery Month, stars ... consumer advocates released today. Consumer advocates were also joined ... who spoke out after losing her fiancée because of ... the doctor had a history of crack cocaine abuse. ...
(Date:9/17/2014)... 17, 2014 /PRNewswire-iReach/ -- ChemImage announced today ... improvements in the development of imaging technology ... normal and diseased tissue that minimizes the ... procedures, lowers surgical costs and potentially enhances ... The clinical and scientific teams ...
Breaking Medicine Technology:Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2
... Calif., Dec. 5, 2011  Radient Pharmaceuticals Corporation  (OTCQX:RXPC) ... In Vitro Diagnostic (IVD) cancer test, announced ... the 2012 Gastrointestinal Cancers Symposium (ASCO Conference) were ... The meeting will be held on January 19-21, ...
... (NASDAQ and MTA: CTIC) announced today an update on ... application ("MAA") for Pixuvri. CTI is seeking a license ... relapsed or refractory aggressive non-Hodgkin,s lymphoma ("NHL") who have ... received the CHMP,s day 180 list of outstanding issues, ...
Cached Medicine Technology:Radient Pharmaceuticals' Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation 2Radient Pharmaceuticals' Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation 3European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 2European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 3European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 4European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 5
(Date:9/17/2014)... 2014 iFitDress.com, a renowned wedding dress manufacturer ... petite evening dresses . All these outfits are now offered ... shipping costs. , “iFitDress.com is a professional company when ... are now busy selling our new collection of petite evening ... order above $800 can get free shipping. All these cheap ...
(Date:9/17/2014)... York, NY (PRWEB) September 18, 2014 ... 5.9 million tons of medical waste in 2014. Due ... disposed of in landfills along with municipal solid waste. ... disposal of regulated medical waste (RMW). This includes disposable ... or other potentially infectious materials. As a result of ...
(Date:9/17/2014)... Los Angeles, CA (PRWEB) September 17, 2014 ... U.S. Food & Drug Administration report titled “Adverse ... Intranasal Splint as a Dermal Filler,” unapproved use ... filler injections has resulted in adverse reactions including ... acid based products with FDA approval for cosmetic ...
(Date:9/17/2014)... PA (PRWEB) September 17, 2014 Fitness-conscious ... exercise - even when they're already practicing or participating ... was inspired to design a special fitness system that ... playing baseball or football," said an inventor from Maynard, ... MOBILITY FITNESS SYSTEM, which maximizes a body workout while ...
(Date:9/17/2014)... has been reserved for the very healthy. Astronauts ... highest physical and psychological standards to prepare them ... of commercial spaceflight, average people can now fly ... very little information about what medical conditions or ... spaceflight environment, as most medical conditions have never ...
Breaking Medicine News(10 mins):Health News:Elegant Petite Evening Dresses Introduced By Renowned Supplier iFitDress.com 2Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Simon Ourian, Kim Kardashian's Cosmetic Surgeon, Warns About Illegal Use of Expression as a Dermal Filler 2Health News:Space: The final frontier… open to the public 2
... , , ATLANTA, ... related to the diagnosis and treatment of infertility with ovulation induction ... emotional, scientific and financial aspects. Discussions include information about age related ... donor sperm or donor eggs. , , ...
... , , ... officials announced today that Tennessee residents have saved over $7.3 million ... the free statewide prescription assistance program. Tennessee Drug Card, which ... 2007. The program has no restrictions to membership, no income requirements, ...
... , , MINNEAPOLIS, July 27 ... world,s population, often resulting in patches of dry skin, and little red ... the teenage years but may continue throughout adulthood. There is no ... B. Fleischer, professor and chair of the department of dermatology at Wake ...
... exercise at lower concentrations , MONDAY, July 27 (HealthDay ... have a negative effect on lung function in healthy people, ... allows for ozone concentrations of up to 75 parts per ... that 6.6 hours exposure to mean ozone concentrations as low ...
... , LA JOLLA, Calif., July 27 For the ... business leaders, community members and cancer survivors "surfing for a cure" ... held at UC San Diego,s Scripps Institution of Oceanography. Now, members ... Longboard Invitational portion of the event that takes place on Sunday, ...
... New York, NY The Lymphoma Research Foundation (LRF) is ... Research Foundation Clinical Investigator Career Development Award has been ... the Nebraska Medical Center in Omaha, Nebraska. ... is broadly categorized into Hodgkin lymphoma (HL) and non-Hodgkin ...
Cached Medicine News:Health News:Tennessee Drug Card Has Saved Residents Over $7.3 Million 2Health News:What Is Keratosis Pilaris (KP)? 2Health News:'Safe' Ozone Levels May Not Be for Some 2Health News:Moores UCSD Cancer Center Luau & Longboard Invitational Celebrates 16 Years of 'Surfing for a Cure' to Raise Funds for Cancer Research 2Health News:Moores UCSD Cancer Center Luau & Longboard Invitational Celebrates 16 Years of 'Surfing for a Cure' to Raise Funds for Cancer Research 3Health News:Moores UCSD Cancer Center Luau & Longboard Invitational Celebrates 16 Years of 'Surfing for a Cure' to Raise Funds for Cancer Research 4Health News:Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research 2
The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... The HAAG-STREIT OM 900 Ophthalmometer uses ... the three requirements of Helmholtz: 1. The ... of the distance between the Ophthalmometer and ... are independent of the distance between the ...
Medicine Products: